ABSTRACT We studied the effect of propranolol on the diet-induced coronary artery atherosclerosis (CAA) in 30 adult male cynomolgus monkeys living in social groupings of five animals each. Animals in the "treated" segment (n = 15) consumed propranolol, which was mixed into an atherogenic diet. Animals in the "untreated" group (n = 15) consumed only the atherogenic diet. Finally, the social groupings were subjected to disruption through monthly redistribution of monkeys among the groups within each treatment segment. The experiment lasted 26 months, following which all animals underwent autopsy during which the coronary arteries were evaluated for atherosclerosis. Regarding atherosclerosis, we observed a significant interaction between social status and experimental condition (p < .03). Socially dominant animals had (as in previous studies) significantly exacerbated CAA, but only in the untreated segment; the effect of social dominance on CAA was abolished by long-term administration of propranolol. The antiatherogenic effect of propranolol on dominant animals was independent of the influences of serum lipid concentrations, blood pressure, and resting heart rate. We conclude that treatment with ,B-adrenergic-blocking agents may confer a degree of protection against CAA among individuals behaviorally predisposed to coronary heart disease.
THERE IS increasing evidence that the behavioral attributes of individuals contribute to risk for atherosclerosis and coronary heart disease (CHD). Among human beings, the so-called type A behavior pattern (and, more specifically, the propensity to experience excessive anger or hostility) has been found to be predictive of CHD events in prospective studies of initially healthy individuals.1-7 Similarly, we have observed that when male cynomolgus monkeys fed atherogenic diets are housed in an unstable or stressful social setting, the highly aggressive and competitive dominant animals develop greater coronary artery atherosclerosis than their more submissive, subordinate counterparts.8' 9 Because these associations also appear to be independent of concomitant variability in "established" risk factors for CHD and atherosclerosis, such as hyperlipoproteinemia, elevated blood pressure, and (among human beings) cigarette smoking and age, the mechanism(s) mediating behavioral influences on coronary disease remain unclear.
In this regard, several investigators have proposed that recurrent activation of the sympathetic nervous system (such as occurs with intense behavioral arousal) may initiate or exacerbate atherogenesis, possibly via hemodynamic disturbances associated with abrupt rises in heart rate and blood pressure. 1013 Specifically, it has been hypothesized that cardiovascular responses to behavioral stimuli, if appreciable in magnitude and frequent in occurrence, may cause injury to the arterial endothelium. 14, 15 Such injury may then be followed by accumulation of plasma lipoproteins in the intima, the release of mitogenic substances by the damaged endothelium or by activated platelets, and intimal smooth muscle cell proliferation.6, 17 If behavioral stimuli can potentiate atherogenesis through accompanying activation of the sympathetic nervous system, it is also reasonable to hypothesize that individuals exhibiting the most pronounced cardiovascular reactions under "stress" will similarly be at heightened risk for exacerbated atherosclerosis. Such speculation is consistent, for example, with the observation that type A ("coronary prone") individuals experience larger cardiovascular responses than do their type B (noncoronary-prone) counterparts when exposed to frustrating mental tasks or other psychological stressors.i8, 19 To the extent that cardiovascular responses to behavioral challenges may promote atherogenesis, it seemed reasonable to us that long-term administration of a ,8-adrenoreceptor-blocking agent would be protective against coronary artery atherosclerosis in the behaviorally predisposed individual. The purpose of the present experiment was to test this hypothesis in a study of male cynomolgus macaques fed a moderately atherogenic diet. All monkeys were housed for 2 years in repeatedly reorganized (i.e., stressful) social groupings; half of the animals were administered propranolol throughout the investigation, and the social status of each monkey was assessed on a recurrent basis. As noted above, socially dominant monkeys develop greater coronary atherosclerosis than do subordinates when both are housed under unstable social conditions. To the extent that such effects might be mediated by cardiac responses to the stress of recurrent social reorganization, it may be predicted that untreated dominants in this study would have: (1) more extensive coronary artery atherosclerosis than similarly dominant monkeys receiving propranolol, and (2) as in previous experiments, 7more extensive atherosclerosis than subordinate animals, irrespective of the antiatherogenic effects of propranolol. The results reported here are consistent with the predicted effects.
Methods
Animals. The study animals were 30 male cynomolgus monkeys (Macacafascicularis) imported from Singapore as adults (average age = 7.0 years, estimated by dentition). This species has a well-known susceptibility to diet-induced coronary artery atherosclerosis,20 and has previously proven useful in studies of behavioral influences on coronary artery atherosclerosis. 9 21 Experimental design and procedures. The 30 monkeys were assigned in equal numbers to either a propranolol-"treated" or "untreated" condition. Within each condition, monkeys were divided randomly into three five-member social groups, and all groups were housed in identical pens measuring 3.0 x 3.2 x 2.5 m (with outdoor exposure). Further, animals in both treatment conditions were fed a moderately atherogenic diet. This diet ( from 24 contributed to analyses reported here. The remainder of animals were lost to the experiment, but equal numbers from the treated and untreated groups did not contribute data: four animals died prematurely of chronic infections unrelated to the study, one was removed from social housing for a lengthy period due to injury, and the arteries of a sixth monkey were damaged during preparation. Pharmacologic manipulation. In the propranolol-treated group, propranolol was added to the animals' diet in the amount of 0.2 mg/calorie/day (equivalent to a human dose of about 400 mg/day). Propranolol was included in the diet on a caloric basis because of the relatively high metabolic rates of cynomolgus monkeys (e.g., a 5 kg male consumes nearly one-third the calories of a 75 kg human being). The For each social reorganization, the number of animals over which a given monkey was dominant was recorded as a dominance "score" for that animal. These scores were next averaged for each monkey over all experimental periods, and animals in each condition were ranked in the order of their scores. All animals falling above the median of the resulting distribution of social rankings were identified as dominant monkeys in the experiment; the remaining, lesser-ranked animals were designated subordinates. In instances involving ties (n = 1), the ratio of aggressive-to-submissive interaction served as a second discriminator. Importantly, differences in the social status of these monkeys were relatively stable over the course of the experiment, and equally so in both the treated and untreated groups. On the average, animals categorized as dominant were found to be high ranking in 81% of experimental periods among the propranolol-treated monkeys, and in 82% of experimental periods among untreated animals. Conversely, subordinate monkeys were found to be low ranking in 81% and 79% of experimental periods, respectively, in the treated and untreated groups. Heart rate. Periodic heart rate and blood pressure measurements were obtained to determine the effectiveness of the pharmacologic treatment. Heart rate recordings were made in two separate contexts, referred to here as "controlled observations" and "casual measurements." For all recordings, animals were first anesthetized and fitted with portable electrocardiographic (ECG) telemetry units (Keuffel & Esser, Model TM-8 patient monitors); these devices were secured beneath nylon mesh monkey-jackets and maintained in place for several days. Heart rates were monitored in a laboratory space removed from the animals, and all measurements were taken on days following animals' recovery from anesthesia.
For the controlled observations, animals' heart rates were recorded under three standardized conditions, termed "baseline," "stress," and "minimal stimulation." 13 The baseline heart rates were obtained during a period of relative quiet when no human beings were visible to the monkeys. Stress heart rate measurements were collected during presentation by the experimentor of a standard 15 min challenge involving threatened capture. Heart rate measurements under minimal stimulation were obtained in the same setting (i.e., in the experimentor's presence) but without threat. Heart rate recordings under these conditions were obtained on four occasions, once before assignment of animals to the treated and untreated groups (while animals were housed in five-member preexperimental groups) and at 9 month intervals thereafter.
The second context for heart rate evaluation, casual measurement, involved the continuous monitoring of heart rate over 15 consecutive hr (specifically, 6 P.M. to 9 A.M.). For purposes of analysis, heart rates recorded during these hours were collapsed to yield a single value for each monkey over the hours 6 P.M. to 1 31 34 measurement.
The extent of atherosclerosis in each section ofeach artery was highly correlated with the mean extent of lesion for that artery (LAD, r = .92; LCX, r = .96; RCA, r = .95). Hence, for purposes of analysis, the extent ofcoronary artery atherosclerosis for each animal was expressed as the mean intimal area (in mm2) calculated for each of the three coronary arteries. The extent of atherosclerosis in each individual artery was, in turn, highly correlated with the mean extent of lesion for each animal as determined for all 15 sections (LAD, r = .87; LCX, r = .93; RCA, r = .81).
Results
Coronary artery atherosclerosis. There were 12 dominant and 12 subordinate monkeys among the 24 animals whose data contribute to these analyses; further, the dominant and subordinate animals were distributed equally in the treated and untreated groups. The mean intimal areas (across all three coronary arteries) of dominant and subordinate animals in the treated and untreated groups are presented in figure 1 figure 1) ; no significant differences were observed in pairwise comparisons among the latter three groups. Hence, while socially dominant animals in the untreated group developed greater coronary artery atherosclerosis than their subordinate counterparts, the influence of social dominance on coronary atherogenesis was not evident among monkeys that had been administered propranolol over the course of the experiment. For purposes of comparison, figure 1 Heart rate and blood pressure. There were no preexperimental differences between the treatment groups in either heart rate or mean blood pressure. However, it was expected that during the experiment, propranololtreated animals would have significantly lower heart rate and blood pressure than untreated controls. As indicated in table 4, this prediction was supported across all heart rate and blood pressure recordings; in each instance the analysis of variance revealed a highly significant main effect of experimental condition. For heart rate, mean values on baseline (as seen in the 4'controlled observations") were 20 to 25 beats/min lower among the monkeys administered propranolol relative to their untreated counterparts. Interestingly, this difference was even more appreciable in measurements obtained during provocation of the animals (i.e., under stress), when sympathetic nervous influences on myocardial performance would be most pronounced. The "casual" heart rate measurements revealed a similar pattern of significant differences between treated and untreated animals. Finally, heart rate as measured under these conditions did not vary as a function of status, or of the interaction of experimental condition and status. Like heart rate, mean blood pressure measurements (although recorded under ketamine anesthesia) were significantly lower in the propranolol-treated condition than among untreated controls (table 4) . This difference averaged 14 mm Hg across all blood pressure measurements. In contrast, blood pressure did not differ reliably between dominant and subordinate animals, nor was there a significant experimental condition-bystatus interaction.
Psychosocial observations. It was expected that socially dominant animals would engage in aggression more frequently than subordinates, and that the ratio of aggressive to submissive acts would vary similarly as a function of animals' social status. We did not expect affiliative behavior to differ overall between dominant and subordinate monkeys, nor did we predict any specific effects of the administration of propranolol on animals' social behaviors. Results of analyses of variance based on these behavioral indexes, as collected over the course of the experiment, are presented in table 5 . Note that all antagonistic behaviors mild and contact aggression, the aggression-to-submission ratio -successfully discriminated between dominant and subordinate animals. That these effects were not qualified by the experimental condition to which animals had been assigned is indicated by the absence of any significant experimental condition-by-status interactions. Moreover, administration of propranolol itself was associated with no reliable differences in the antagonistic or affiliative behaviors of these animals.
Discussion
Cynomolgus macaques fed atherogenic diets have been shown previously to be a suitable preparation of occlusive atherosclerotic disease of the coronary (8) 110 (7) 145 (3) 145 (9 (7) 114 (5) 120 (7 (5) 84 (6) 104 (4) 116 (7) F= 17.0 NS NS p<.OO1 Blood pressure 68 (9) 59 (3) 78 (5) 77 (3 Other studies have shown that propranolol has antiatherogenic effects in the aortas of cholesterol-fed normotensive and hypertensive rabbits.37-39 However, in one study, propranolol had no significant effect on the coronary artery atherosclerosis of stump-tailed monkeys (Macaca arctoides).40 It is possible that the absence of an antiatherogenic effect in this latter experiment was due to the relatively small dose of propranolol administered to animals (less than one-half the dose used in the current study). Also, the present data suggest that propranolol may only have a retarding effect on atherogenesis in some animals (e.g., dominants), and then only among animals exposed to those social environments that potentiate behavioral influences on atherogenesis (e.g., within disrupted social groupings).
Notably, the psychosocial and pharmacologic effects on coronary atherogenesis in the current experiment 1370 were independent of concomitant variations in serum lipids. Similarly, behavioral influences on atherogenesis were found to be unrelated to variability in serum lipid concentrations in two of our previous studies.8 9 The effect of psychosocial factors on CHD in human beings (particularly as related to type A behavior and hostility)
is also independent of variability in serum lipids.' In this regard, the absence of a deleterious effect of propranolol on HDLC concentrations should be mentioned, since such an effect occasionally has been observed in human beings.41 The HDLC concentrations of macaques exposed to a cholesterol-containing diet are already low (e.g., < 40 mg/dl),and may well be resistant to further pharmacologic reduction.
In the absence of a lipid-mediated treatment effect, other mechanisms must account for the selective influence of propranolol on atherogenesis in dominant animals. /8-Adrenergic-blocking agents differ in lipophilicity and thus in their propensity to cross the blood-brain barrier. As a lipophilic :-blocker, propranolol might have exerted a significant influence on those behaviors associated with risk for coronary artery atherosclerosis (e.g., aggression) due to such central nervous system penetrance.42 However, frequent monitoring of the stereotyped motor patterns typically performed by these monkeys revealed no effects of the drug on animals' antagonistic or affiliative behavior, either overall or in relation to differences in social status. Hence, the current data do not provide support for the speculation that propranolol selectively affected the behavior, and thereby the atherosclerosis, of dominant animals.
Likewise, the generalized effects of propranolol on blood pressure and heart rate, which occurred irre-spective of social status, cannot account for the selective protection accorded dominant animals in the treated groups. These particular heart rate and blood pressure assessments were obtained under the customary and controlled conditions of laboratory measurement (i.e., under anesthesia or at times of convenience to the investigator). However, the atherogenicity of psychosocial factors may result from the marked hemodynamic and/or metabolic adjustments experienced by susceptible animals during naturally occurring periods of social challenge or stress (e.g., competitive encounters). Such physiologic responses are likely to be acute and transient in nature, and therefore elude detection in measurements recorded under usual laboratory conditions. Of particular relevance is our observation in this species that naturally occurring social encounters among group members elicit significant changes in heart rate, and that during active periods of social reorganization such changes are significantly more pronounced in dominant than subordinate monkeys. 43 We hypothesize that propranolol may have exerted an antiatherogenic influence in this study by moderating hemodynamic or metabolic manifestations of a sympathetic nervous system response experienced most appreciably by dominant animals during recurring, although spontaneous, social challenges.
While there may exist other explanations for the present findings, any such explanation must account for propranolol's delimited influence on the coronary artery atherosclerosis of dominant animals. In turn, the fact that both the exacerbation and propranolol-induced inhibition of atherosclerosis were observed only in animals that often show the largest cardiac responses to stress (i.e., dominants) suggests (as noted above) that arousal of the sympathetic nervous system is responsible, to some extent, for modulating the influence of behavioral factors on coronary atherosclerosis in this animal preparation. We thus conclude that treatment with f8-adrenergic blockers may confer a degree of protection against coronary artery atherosclerosis among individuals behaviorally predisposed to CHD.
